Amneal Pharmaceuticals (AMRX) Minority Interest (2017 - 2026)

Amneal Pharmaceuticals' Minority Interest history runs 10 years deep, the most recent figure standing at -$558000.0 for Q1 2026.

• In Q1 2026, Minority Interest fell 100.77% year-over-year to -$558000.0; the TTM figure through Mar 2026 stood at -$558000.0 (down 100.77% YoY), while the FY2025 annual figure was -$535000.0, down 100.82% from the prior year.
• Minority Interest was -$558000.0 for Q1 2026 at Amneal Pharmaceuticals, down from -$535000.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $72.6 million in Q1 2025 to a low of -$558000.0 in Q1 2026.
• Historically, Minority Interest has averaged $38.2 million across 5 years, with a median of $37.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Minority Interest jumped 79.51% in 2023, then tumbled 100.82% in 2025.
• A 5-year view of Minority Interest shows it stood at $24.9 million in 2022, then soared by 65.51% to $41.3 million in 2023, then surged by 57.35% to $65.0 million in 2024, then slumped by 100.82% to -$535000.0 in 2025, then retreated by 4.3% to -$558000.0 in 2026.
• The last three Minority Interest figures came in at -$558000.0 (Q1 2026), -$535000.0 (Q4 2025), and $67.8 million (Q3 2025), per Business Quant data.